|
Delayed
Japan Exchange
12:00:00 09/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,237.00 JPY | -1.91% |
|
-6.38% | +6.88% |
| 01/09 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 01/09 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Market Cap | 4,08900Cr 2.65TCr 2.28TCr 2.14TCr 1.96TCr 3.65TCr 2,51400Cr 3.67TCr 25TCr 9.83TCr 1,28500Cr 9.96TCr 9.74TCr | P/E 2027 * |
11x | P/E 2028 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4,03000Cr 2.61TCr 2.25TCr 2.11TCr 1.93TCr 3.6TCr 2,47800Cr 3.62TCr 25TCr 9.69TCr 1,26600Cr 9.81TCr 9.6TCr | EV / Sales 2027 * |
1.73x | EV / Sales 2028 * | 1.67x |
| Free-Float |
98.88% | Yield 2027 * |
3.52% | Yield 2028 * | 3.65% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4503 | Delayed | |
OTC Markets
| ALPMF | Delayed | |
|
Tradegate
| YPH | Real-time | |
|
Boerse Muenchen
| YPH | Real-time | |
|
Deutsche Boerse AG
| YPH | Delayed | |
|
Börse Stuttgart
| YPH | Delayed |
Last Transcript : Astellas Pharma Inc.
| 1 day | -1.91% | ||
| 1 week | -6.38% | ||
| Current month | -5.67% | ||
| 1 month | -5.33% | ||
| 3 months | +4.31% | ||
| 6 months | -5.61% | ||
| Current year | +6.88% |
| 1 week | 2,233 |  | 2,425.5 |
| 1 month | 2,233 | | 2,455 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 64 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 64 | 01/06/2019 |
| Director/Board Member | 59 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.91% | -6.38% | +31.98% | +2.40% | 2.65TCr | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,00200Cr | |
| -2.22% | -0.76% | +51.08% | +67.61% | 65TCr | |
| -2.99% | -4.31% | +18.59% | +66.94% | 44TCr | |
| -0.41% | +0.03% | +29.51% | +37.57% | 35TCr | |
| -0.95% | -15.43% | +8.82% | +25.76% | 26TCr | |
| -0.17% | -0.70% | -0.70% | +13.24% | 25TCr | |
| -10.08% | -10.26% | +40.32% | +51.55% | 21TCr | |
| -1.17% | -4.29% | -14.76% | -57.79% | 20TCr | |
| -2.88% | -2.19% | +26.54% | +92.95% | 18TCr | |
| Average | -2.13% | -2.41% | +24.35% | +39.19% | 35.7TCr | |
| Weighted average by Cap. | -1.37% | -2.41% | +32.82% | +57.27% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,32900Cr 1.51TCr 1.3TCr 1.22TCr 1.11TCr 2.08TCr 1,43200Cr 2.09TCr 14TCr 5.6TCr 73TCr 5.67TCr 5.55TCr | 2,15500Cr 1.4TCr 1.2TCr 1.13TCr 1.03TCr 1.93TCr 1,32500Cr 1.94TCr 13TCr 5.18TCr 68TCr 5.25TCr 5.13TCr |
| Net income | 36TCr 230.73Cr 198.38Cr 186.64Cr 170.32Cr 317.85Cr 22TCr 319.5Cr 2.21TCr 855.56Cr 11TCr 866.43Cr 847.51Cr | 33TCr 215.64Cr 185.41Cr 174.43Cr 159.18Cr 297.07Cr 20TCr 298.6Cr 2.07TCr 799.6Cr 10TCr 809.76Cr 792.08Cr |
| Net Debt | -5.92TCr -38Cr -33Cr -31Cr -28Cr -53Cr -3.64TCr -53Cr -367.82Cr -142.31Cr -1.86TCr -144.11Cr -140.97Cr | -48TCr -311.71Cr -268.01Cr -252.14Cr -230.1Cr -429.4Cr -30TCr -431.62Cr -2.99TCr -1.16TCr -15TCr -1.17TCr -1.14TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | JP¥2,237.00 | -1.91% | 62,09,400 |
| 08/26/08 | JP¥2,280.50 | -0.98% | 37,79,100 |
| 07/26/07 | JP¥2,303.00 | -2.23% | 33,48,800 |
| 04/26/04 | JP¥2,355.50 | -2.54% | 54,84,800 |
| 03/26/03 | JP¥2,417.00 | +1.15% | 48,91,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
